Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

CAP: a novel era to better quantitate fatty liver?

Mueller S.

J Gastrointestin Liver Dis. 2015 Mar;24(1):11-3. doi: 10.15403/jgld.2014.1121.smu. No abstract available.

2.

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.

de Lédinghen V, Wong GL, Vergniol J, Chan HL, Hiriart JB, Chan AW, Chermak F, Choi PC, Foucher J, Chan CK, Merrouche W, Chim AM, Le Bail B, Wong VW.

J Gastroenterol Hepatol. 2016 Apr;31(4):848-55. doi: 10.1111/jgh.13219.

PMID:
26514665
3.

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.

Lupșor-Platon M, Feier D, Stefănescu H, Tamas A, Botan E, Sparchez Z, Maniu A, Badea R.

J Gastrointestin Liver Dis. 2015 Mar;24(1):35-42. doi: 10.15403/jgld.2014.1121.mlp.

4.

Usefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examinees.

Kim JK, Lee KS, Choi JR, Chung HJ, Jung DH, Lee KA, Lee JI.

Gut Liver. 2015 May 23;9(3):405-10. doi: 10.5009/gnl14202.

5.

Real-time tissue elastography in the assessment of liver stiffness.

Ferraioli G, Lissandrin R, Filice C.

Hepatology. 2013 Aug;58(2):834. doi: 10.1002/hep.26215. Epub 2013 May 27. No abstract available.

PMID:
23280434
6.

Reply: To PMID 22488593.

Hiasa Y, Ochi H, Hirooka M.

Hepatology. 2013 Aug;58(2):834-5. doi: 10.1002/hep.26216. Epub 2013 Jun 24. No abstract available.

PMID:
23280450
7.

How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.

Carvalhana S, Leitão J, Alves AC, Bourbon M, Cortez-Pinto H.

Liver Int. 2014 Jul;34(6):e111-7. doi: 10.1111/liv.12305. Epub 2013 Sep 4.

PMID:
24034415
8.

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

de Lédinghen V, Vergniol J, Capdepont M, Chermak F, Hiriart JB, Cassinotto C, Merrouche W, Foucher J, Brigitte le B.

J Hepatol. 2014 May;60(5):1026-31. doi: 10.1016/j.jhep.2013.12.018. Epub 2013 Dec 28.

PMID:
24378529
9.

Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: controlled attenuation parameter for steatosis.

Berzigotti A.

J Hepatol. 2014 May;60(5):910-2. doi: 10.1016/j.jhep.2014.01.017. Epub 2014 Jan 31. No abstract available.

10.

Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.

Mendes LC, Ferreira PA, Miotto N, Zanaga L, Lazarini MS, Gonçales ESL, Pedro MN, Gonçales FL Júnior, Stucchi RSB, Vigani AG.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):959-966. doi: 10.1097/MEG.0000000000001145.

PMID:
29727388
11.

Noninvasive detection of hepatic steatosis in patients without ultrasonographic evidence of fatty liver using the controlled attenuation parameter evaluated with transient elastography.

Yilmaz Y, Ergelen R, Akin H, Imeryuz N.

Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1330-4. doi: 10.1097/MEG.0b013e3283623a16.

PMID:
23660937
12.

[Liver stiffness in animals with glutamate-induced obesity (according to shear wave ultrasound elastography)].

Kobyliak NM, Dynnyk OB, Mykhal'chyshyn HP, Bodnar PM.

Lik Sprava. 2013 Apr-May;(3):85-9. Ukrainian.

PMID:
25016754
13.

Fat and fiber: how the controlled attenuation parameter complements noninvasive assessment of liver fibrosis.

Wong GL, Wong VW.

Dig Dis Sci. 2015 Jan;60(1):9-12. doi: 10.1007/s10620-014-3429-3. Epub 2014 Nov 16. No abstract available.

PMID:
25399331
14.

Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.

Chon YE, Jung KS, Kim SU, Park JY, Park YN, Kim DY, Ahn SH, Chon CY, Lee HW, Park Y, Han KH.

Liver Int. 2014 Jan;34(1):102-9. doi: 10.1111/liv.12282. Epub 2013 Sep 13.

PMID:
24028214
15.

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.

Sasso M, Miette V, Sandrin L, Beaugrand M.

Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):13-20. doi: 10.1016/j.clinre.2011.08.001. Epub 2011 Sep 15. Review.

PMID:
21920839
16.

[Efficiency of FibroScan and FibroTouch in liver stiffness measurement and fat quantification: a comparative analysis].

Zeng J, Sun WL, Chen GY, Pan Q, Yan SY, Sun C, Xu ZJ, Fan JG.

Zhonghua Gan Zang Bing Za Zhi. 2016 Sep 20;24(9):652-658. doi: 10.3760/cma.j.issn.1007-3418.2016.09.004. Chinese.

PMID:
27788720
17.

Acoustic radiation force impulse elastography of the liver: can fat deposition in the liver affect the measurement of liver stiffness?

Motosugi U, Ichikawa T, Niitsuma Y, Araki T.

Jpn J Radiol. 2011 Nov;29(9):639-43. doi: 10.1007/s11604-011-0607-5. Epub 2011 Sep 29.

PMID:
21956369
18.

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.

Ferraioli G, Calcaterra V, Lissandrin R, Guazzotti M, Maiocchi L, Tinelli C, De Silvestri A, Regalbuto C, Pelizzo G, Larizza D, Filice C.

BMC Gastroenterol. 2017 May 4;17(1):61. doi: 10.1186/s12876-017-0617-6.

19.

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V.

Ultrasound Med Biol. 2010 Nov;36(11):1825-35. doi: 10.1016/j.ultrasmedbio.2010.07.005. Epub 2010 Sep 27.

PMID:
20870345
20.

What we need to know when performing and interpreting US elastography.

Park SH, Kim SY, Suh CH, Lee SS, Kim KW, Lee SJ, Lee MG.

Clin Mol Hepatol. 2016 Sep;22(3):406-414.

Supplemental Content

Support Center